RAPT Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for RAPT Therapeutics, Inc. (RAPT), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are RAPT insiders buying or selling?
RAPT Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since November 2019, Trabud has recorded 122 Form 4 filings for RAPT: 30 buys ($48.5M) and 92 sells ($82.0M).
Source: SEC EDGAR Form 4
Key Statistics (November 2019 – Jan 8, 2024)
Total Form 4 filings
122
SEC EDGAR
Insider filers
12
Insider buys (30)
$48.5M
Insider sells (92)
$82.0M
Insider sentiment
Net sellingNet insider flow of $33.5M in net selling since November 2019.
Recent RAPT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | Dirk G. Brockstedt | CHIEF SCIENTIFIC OFFICER | Sale | 898 | $22.78 | $20.5K | SEC ↗ |
| Dec 22, 2023 | William HO | Chief Medical Officer | Sale | 2.5K | $21.68 | $54.2K | SEC ↗ |
| Nov 29, 2023 | William HO | Chief Medical Officer | Sale | 1.5K | $13.72 | $20.6K | SEC ↗ |
| Oct 4, 2023 | William HO | Chief Medical Officer | Sale | 2.5K | $15.77 | $39.4K | SEC ↗ |
| Aug 22, 2023 | William HO | Chief Medical Officer | Sale | 2.5K | $18.92 | $47.3K | SEC ↗ |
| Apr 20, 2023 | William HO | Chief Medical Officer | Sale | 5.0K | $18.88 | $94.4K | SEC ↗ |
| Mar 15, 2023 | Wendye Robbins | Director | Purchase | 5.0K | $19.52 | $97.6K | SEC ↗ |
| Mar 13, 2023 | William HO | Chief Medical Officer | Sale | 5.0K | $29.62 | $148.1K | SEC ↗ |
| Jan 26, 2023 | William HO | Chief Medical Officer | Sale | 5.0K | $30.00 | $150.0K | SEC ↗ |
| Jan 20, 2023 | William HO | Chief Medical Officer | Sale | 5.0K | $25.56 | $127.8K | SEC ↗ |
| Jan 9, 2023 | Dirk G. Brockstedt | Chief Scientific Officer | Sale | 742 | $21.97 | $16.3K | SEC ↗ |
| Dec 30, 2022 | William HO | Chief Medical Officer | Sale | 5.0K | $18.03 | $90.2K | SEC ↗ |
| Nov 29, 2022 | William HO | Chief Medical Officer | Sale | 5.0K | $17.87 | $89.3K | SEC ↗ |
| Nov 3, 2022 | William HO | Chief Medical Officer | Sale | 5.0K | $22.32 | $111.6K | SEC ↗ |
| Oct 14, 2022 | William HO | Chief Medical Officer | Sale | 2.0K | $21.52 | $43.0K | SEC ↗ |
| Jul 13, 2022 | William HO | Chief Medical Officer | Sale | 2.0K | $19.95 | $39.9K | SEC ↗ |
| May 27, 2022 | COLUMN GROUP II, LP | 10% Owner | Purchase | 1.9K | $12.45 | $23.7K | SEC ↗ |
| May 27, 2022 | Tim Kutzkey | 10% Owner | Purchase | 1.9K | $12.45 | $23.7K | SEC ↗ |
| May 25, 2022 | COLUMN GROUP II, LP | 10% Owner | Purchase | 26.6K | $12.19 | $323.7K | SEC ↗ |
| May 25, 2022 | Tim Kutzkey | 10% Owner | Purchase | 26.6K | $12.19 | $323.7K | SEC ↗ |
| May 12, 2022 | COLUMN GROUP II, LP | 10% Owner | Purchase | 1.3M | $10.67 | $13.3M | SEC ↗ |
| May 12, 2022 | Tim Kutzkey | 10% Owner | Purchase | 1.3M | $10.67 | $13.3M | SEC ↗ |
| May 12, 2022 | Rodney KB Young | Chief Financial Officer | Purchase | 5.0K | $10.53 | $52.6K | SEC ↗ |
| May 5, 2022 | Dirk G. Brockstedt | Chief Scientific Officer | Sale | 720 | $15.05 | $10.8K | SEC ↗ |
| Apr 12, 2022 | Dirk G. Brockstedt | Chief Scientific Officer | Sale | 2.6K | $23.05 | $61.0K | SEC ↗ |
Showing the 25 most recent of 122 Form 4 filings for RAPT Therapeutics, Inc..
Most active RAPT insiders
- William HO55 filings
- Dirk G. Brockstedt22 filings
- Wendye Robbins16 filings
- Tim Kutzkey14 filings
- Brian Russell Wong3 filings
Ask anything about RAPT insider activity
Use Trabud's AI agent to query RAPT Therapeutics, Inc.'s Form 4 history in plain English — "Show me RAPT CEO purchases this year" or compare it against any other ticker.
Open the AI agentRAPT insider trading FAQ
Are RAPT Therapeutics, Inc. insiders buying or selling?
RAPT Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since November 2019, Trabud has recorded 122 Form 4 filings for RAPT: 30 buys ($48.5M) and 92 sells ($82.0M). Over the full record that is net selling of $33.5M.
How many insiders trade RAPT stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for RAPT Therapeutics, Inc.. The most recent filing was accepted on Jan 8, 2024.
Where does Trabud get RAPT insider trading data?
All RAPT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.